Are long-term risks known yet?

THE European Association for the study of obesity has issued new guidelines stating weight loss drugs should be the first treatment for patients. European doctors argue that these jabs can be used as powerful slimming aids and reduce other health concerns such as such as high blood pressure and type 2 diabetes.

All to discuss further with Professor Donal O’Shea, Clinical Lead for Obesity at the HSE.